StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences gross margin

Gross margin is gross profit as a percentage of revenue.

Panacea Life Sciences's gross margin for the twelve months ending Mar 31, 2024 was 56.5%. For fiscal 2023 it was 47.0%, against 24.4% the year before. The highest annual figure on record is 47.0% in fiscal 2023.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 202347.0%+22.7
FY2022Dec 31, 202224.4%−1.9
FY2021Dec 31, 202126.2%+4.1
FY2020Dec 31, 202022.2%+514.1
FY2019Dec 31, 2019-491.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 202463.1%+29.8
Q4 FY2023Dec 31, 202356.9%+22.8
Q3 FY2023Sep 30, 202342.1%+29.2
Q2 FY2023Jun 30, 202350.8%+21.4
Q1 FY2023Mar 31, 202333.3%+11.8
Q4 FY2022Dec 31, 202234.1%+32.5
Q3 FY2022Sep 30, 202212.9%−35.2
Q2 FY2022Jun 30, 202229.4%+8.7
Q1 FY2022Mar 31, 202221.5%−14.1
Q4 FY2021Dec 31, 20211.6%+4.7
Q3 FY2021Sep 30, 202148.1%+164.4
Q2 FY2021Jun 30, 202120.7%−31.0
Q1 FY2021Mar 31, 202135.6%+103.1
Q4 FY2020Dec 31, 2020-3.1%+1306.0
Q3 FY2020Sep 30, 2020-116.3%−49.3
Q2 FY2020Jun 30, 202051.7%+118.6
Q1 FY2020Mar 31, 2020-67.5%−88.6
Q4 FY2019Dec 31, 2019-1309.1%–
Q3 FY2019Sep 30, 2019-66.9%–
Q2 FY2019Jun 30, 2019-66.9%–
Q1 FY2019Mar 31, 201921.2%–

More Panacea Life Sciences figures

See a number that looks wrong?